←Hematology & Oncology
HIT (heparin-induced thrombocytopenia)
📚
📚 Library › 🩸 Hematology & Oncology › Platelets & clotting
🧷

HIT (heparin-induced thrombocytopenia)

4Ts first, stop ALL heparin, start a non-heparin anticoagulant, no platelets, no early warfarin.

HIT4TsargatrobanPF4thrombocytopenia
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2018 ASH HIT guideline · CHEST antithrombotic guidelines
🧠 Pathophysiology in 60 seconds🔎 Diagnosis — 4Ts💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Calculate 4Ts before ordering tests. 0–3 = low → HIT very unlikely, don't send the test, keep heparin.
  • 4Ts ≥4 → stop ALL heparin (flushes, LMWH, heparin-coated lines) and start a non-heparin anticoagulant — even before results.
  • Argatroban (liver OK, kidney failure OK), bivalirudin, fondaparinux, or a DOAC (stable patients).
  • No platelet transfusions (unless bleeding). No warfarin until platelets ≥150 k; overlap ≥5 days.
  • HIT is pro-thrombotic — check leg Dopplers. Treat 3 months if thrombosis; 4 weeks–3 months if isolated HIT.

🧠 Pathophysiology in 60 seconds

⌄
  • Heparin binds platelet factor 4 (PF4) → new shape → body makes IgG antibodies against PF4–heparin.
  • Antibody complexes activate platelets via FcγRIIa → platelets clump (count falls) and release procoagulants → thrombosis (venous > arterial).
  • Platelets low but clotting — the paradox. Bleeding is rare.
  • Timing: antibodies need 5–10 days to form (or <1 day if heparin in last 30–100 days — "rapid onset").

🔎 Diagnosis — 4Ts

⌄
2 points 1 point 0 points
Thrombocytopenia Fall >50% and nadir ≥20 k Fall 30–50% or nadir 10–19 k <30% or nadir <10 k
Timing Day 5–10, or ≤1 day with recent heparin (≤30 d) >day 10, unclear, or ≤1 day with heparin 30–100 d ago ≤4 days, no recent heparin
Thrombosis New thrombosis, skin necrosis, systemic reaction after bolus Progressive/recurrent/suspected None
oTher cause None Possible Definite (sepsis, DIC, drugs, bleed)

0–3 low · 4–5 intermediate · 6–8 high.

  • Intermediate/high → PF4 immunoassay (ELISA). High OD (>1.0–2.0) = more likely.
  • Serotonin release assay (SRA) confirms (functional, days).
  • Lower-extremity Doppler ultrasound in all confirmed/suspected HIT (silent DVT is common).

💊 Management

⌄
Drug Use Note
Argatroban IV; liver clearance → good in renal failure Raises INR (complicates warfarin switch); reduce in liver disease
Bivalirudin IV; short half-life; renal adjust Cardiac procedures
Fondaparinux SC daily, weight-based Avoid CrCl <30
Rivaroxaban / apixaban Stable patients, no high bleeding risk Use VTE treatment doses
  • HIT with thrombosis (HITT): 3 months.
  • Isolated HIT: at least until platelets recover; many treat 4 weeks–3 months (high early thrombosis risk).
  • Warfarin only after platelets ≥150 k; start low, overlap ≥5 days and until INR therapeutic 24 h (risk of venous limb gangrene from protein C drop).
  • Avoid heparin in the future when possible; document allergy.
  • Cardiac surgery with remote HIT (antibody negative) → brief intra-op heparin is acceptable.

⚠️ Pitfalls

⌄
  • Sending PF4 ELISA on everyone with low platelets (false positives → harm).
  • Stopping heparin without starting another anticoagulant.
  • Forgetting heparin flushes and coated catheters.
  • Transfusing platelets "because count is low."

🎓 Board corner

⌄
Stem Answer
Day 7 of heparin, platelets 220 → 90 k, new DVT HIT → stop heparin, start argatroban
Platelets fall day 2 of heparin, no prior exposure Not HIT (too early)
HIT + CrCl 15 Argatroban
HIT, platelets 60 k, on argatroban, start warfarin? Wait until ≥150 k
Skin necrosis at LMWH injection site HIT

📚 References

⌄
  • Cuker A, et al. ASH 2018 guidelines for VTE: HIT. Blood Adv. 2018;2:3360.
  • Lo GK, et al. 4Ts score. J Thromb Haemost. 2006;4:759.
  • Warkentin TE. HIT. NEJM. 2015.
↩︎ Back to 🩸 Hematology & Oncology